A Comparative Study of Hybrid Models in Health Misinformation Text Classification
Sikosana, Mkululi, Ajao, Oluwaseun, Maudsley-Barton, Sean
–arXiv.org Artificial Intelligence
This study evaluates the effectiveness of machine learning (ML) and deep learning (DL) models in detecting COVID-19-related misinformation on online social networks (OSNs), aiming to develop more effective tools for countering the spread of health misinformation during the pan-demic. The study trained and tested various ML classifiers (Naive Bayes, SVM, Random Forest, etc.), DL models (CNN, LSTM, hybrid CNN+LSTM), and pretrained language models (DistilBERT, RoBERTa) on the "COVID19-FNIR DATASET". These models were evaluated for accuracy, F1 score, recall, precision, and ROC, and used preprocessing techniques like stemming and lemmatization. The results showed SVM performed well, achieving a 94.41% F1-score. DL models with Word2Vec embeddings exceeded 98% in all performance metrics (accuracy, F1 score, recall, precision & ROC). The CNN+LSTM hybrid models also exceeded 98% across performance metrics, outperforming pretrained models like DistilBERT and RoBERTa. Our study concludes that DL and hybrid DL models are more effective than conventional ML algorithms for detecting COVID-19 misinformation on OSNs. The findings highlight the importance of advanced neural network approaches and large-scale pretraining in misinformation detection. Future research should optimize these models for various misinformation types and adapt to changing OSNs, aiding in combating health misinformation.
arXiv.org Artificial Intelligence
Oct-8-2024
- Country:
- North America > United States
- New York > New York County > New York City (0.04)
- Europe
- Iceland (0.04)
- Poland > Greater Poland Province
- Poznań (0.05)
- Asia > Middle East
- Iran (0.04)
- Oman > Muscat Governorate
- Muscat (0.04)
- North America > United States
- Genre:
- Research Report > New Finding (0.68)
- Industry:
- Media > News (1.00)
- Health & Medicine > Therapeutic Area
- Infections and Infectious Diseases (1.00)
- Immunology (1.00)
- Technology: